# Serán BioScience plans commercial facility in Bend, Oregon

Serán BioScience announced a $200 million strategic growth transaction led by Bain Capital Life Sciences to build a new commercial-scale manufacturing facility in Bend, Oregon, expected to be completed in 2027.

- Type: New facility
- Announced: 2024-09-17
- Where: Bend, Oregon, United States
- Value: $200.0M
- Starts operating: 2027
- Status: announced
- Products: spray drying, particle engineering, finished dose manufacturing
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Serán BioScience](https://endata.com/companies/79855.md)
- [Vivo Capital](https://endata.com/companies/20844.md) (investor)
- [Bain Capital Life Sciences](https://endata.com/companies/79856.md) (investor)

## Sources

- [seranbio.com](https://www.seranbio.com/news/seran-bioscience-announces-200-million-strategic-growth-transaction-and-plans-for-new-commercial-facility), 2024-09-17: "The partnership will support Serán’s continued growth with the build out of a new commercial-scale manufacturing facility that will enable the company to provide integrated capabilities across multiple drug delivery and final dose formats."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.